Sotradecol (Sodium Tetradecyl Sulfate) Injection

OCTOBER 01, 2005

Bioniche Life Sciences Inc (Belleville, Ontario) has introduced Sotradecol Injection to the US market. The product is approved by the FDA for the treatment of small, uncomplicated varicose veins of the lower extremities. Sotradecol Injection is used in sclerotherapy (nonsurgical vein removal). An estimated 1.7 million individuals undergo sclerotherapy each year in the United States. Sotradecol Injection is available in 2 strengths, 1% and 3%, and is packaged in 2-mL vials. For more information, visit www.bioniche.com, or call 888-258-4199.



SHARE THIS SHARE THIS
0

A Fast, Easy Way to Inform Parents About Vaccinations

Officials with the Centers for Disease Control and Prevention have prepared an informational video on this topic.

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.